RE:RE:Bruce Tatter on BNNHere are his comments for both CXR and VRX. GLTA Concordia Healthcare 2016-05-30 HOLD
An acquiring company, but hasn’t gone through the same level of scrutiny that Valeant (VRX-T) has. Any company that used too much debt, rather than shares, to do acquiring last summer, had too much debt on its balance sheet. The good news with all these pharma companies is that they are very different than resource companies, etc. They generate huge amounts of free cash flow, and their businesses don’t fall apart right away when they stop reinvesting. It is very likely the stock is worth more than what it is trading at.
Login to show your approval Login to show your disapproval / Be the first to comment
Price:
$43.680
Subject:
NORTH AMERICAN - LARGE
Bias:
OPTIMISTIC
Owned:
Unknown
2016-05-30 BUY Valeant Pharmaceuticals
(Market Call Minute.) Down 90% and a free cash flow generator, and can earn more than its free cash flow and everyone hates it.
Login to show your approval Login to show your disapproval / Be the first to comment
Price:
$37.800
Subject:
NORTH AMERICAN - LARGE
Bias:
OPTIMISTIC
Owned:
Unknown